New patent for Horizon drug PROCYSBI

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for PROCYSBI
Annual Drug Patent Expirations for PROCYSBI

Procysbi is a drug marketed by Horizon and is included in two NDAs. There are twelve patents protecting this drug.

Drug patent litigation for PROCYSBI.

This drug has eighteen patent family members in eighteen countries.

The generic ingredient in PROCYSBI is cysteamine bitartrate. Additional details are available on the cysteamine bitartrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top